Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

scMC effectively separates biological signals from technical noise in single-cell genomics data.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Lef1 helps adult skin cells maintain their ability to heal wounds and regenerate hair, but the study's methods and conclusions have been questioned.

Using combined fat and growth factors can effectively treat hair loss after facial fillers.

The follicular unit extraction technique is a successful treatment for male hair loss with over 90% hair survival rate and less than 6% complications.

The treatment improved hair growth in three patients with alopecia.

Human skin cells with stem-like features can help create new hair follicles and sebaceous glands when combined with other cells.

FGF18 may influence hair loss in dogs.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

EPI-NCSCs from hair follicles may help treat brain development issues in mice.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Human amniotic fluid stem cell-derived exosomes improve wound healing and reduce scarring.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

CD44 variant changes start alopecia areata, but don't maintain it.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

Certain genes are linked to the risk of developing Alopecia Areata.

Fiber implants effectively treat permanent hair loss with few complications.

Diabetic patients' stem cells make vascular grafts more prone to clots, but new methods may improve grafts.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Skin-derived stem cells grow faster and are easier to obtain than hair follicle stem cells, but both can become various cell types.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Farudodstat may effectively treat alopecia areata without harming hair follicles.